Article
NRAGE promotes the malignant phenotype of hepatocellular carcinoma
15 Jan 2016
Abstract excerpt
Hepatocellular carcinoma (HCC) is a fatal disease, primarily due to the limited effective therapies available for patients with advanced or recurrent stages of the disease. Therefore, in order to improve patient prognosis, it is important to identify an informative biomarker for HCC progression, as well as a molecular target for therapy. Neurotrophin receptor‑interacting melanoma antigen‑encoding protein (NRAGE),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
